Clinical trial
Prospective Observation Study of Insulin Sensitivity During and After…
NCT00456144 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00456144 |
|---|---|
| Title | Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer |
| Official title | Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone (GnRH) Agonist Therapy for Prostate Cancer |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Gonadotropin Releasing Hormone Agonist Therapy |
| Enrollment | 36 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2012 |
| Completion | Sep 1, 2012 |
| First posted | Apr 4, 2007 |
| Last update posted | Jul 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: